tm
Seeing Is Believing
tm
Seeing Is Believing
VRDN is currently covered by 11 analysts with an average price target of $35.5. This is a potential upside of $15.95 (46.15%) from yesterday's end of day stock price of $24.29.
Viridian Therapeutics's activity chart (see below) currently has 160 price targets and 154 ratings on display. The stock rating distribution of VRDN is 91.18% BUY and 8.82% HOLD.
Analysts average stock forecasts to be materialized ratio is 25.66% with an average time for these price targets to be met of 215.57 days.
Highest price target for VRDN is $61, Lowest price target is $20, average price target is $35.5.
Most recent stock forecast was given by LISA WALTER from RBC on 07-Aug-2026. First documented stock forecast 20-Jan-2021.
Currently out of the existing stock ratings of VRDN, 31 are a BUY (91.18%), 3 are a HOLD (8.82%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Aug-2025
$36
$11.71 (48.21%)
$35
Buy Since 30-May-2023
$39
$14.71 (60.56%)
$38
Buy Since 19-Dec-2022
$34
$9.71 (39.98%)
$32
Buy Since 11-Aug-2021
$43
$18.71 (77.03%)
$31
Hold Since 07-Aug-2025
$31
$6.71 (27.62%)
$20
What is VRDN (Viridian Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on VRDN (Viridian Therapeutics) with a proven track record?
Which analyst has the most public recommendations on VRDN (Viridian Therapeutics)?
Which analyst is the currently most bullish on VRDN (Viridian Therapeutics)?
Which analyst is the currently most reserved on VRDN (Viridian Therapeutics)?
